Gastrinoma

Current treatment options in oncology

Volumn 2, Issue 4, 2001, Pages 337-346

  Li, Michelle L ^a,b   Norton, Jeffrey A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIULCER AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP; SOMATOSTATIN;

CATHETER ABLATION; DRUG ANTAGONISM; EPIDEMIOLOGY; GASTRECTOMY; GASTRINOMA; GENETICS; HUMAN; LIVER TRANSPLANTATION; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PARATHYROIDECTOMY; REVIEW; SECRETION; STOMACH ACID; VAGOTOMY; ZOLLINGER ELLISON SYNDROME;

ANTI-ULCER AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETER ABLATION; COMBINED MODALITY THERAPY; ENZYME INHIBITORS; EPIDEMIOLOGIC METHODS; GASTRECTOMY; GASTRIC ACID; GASTRINOMA; GASTRINS; HISTAMINE H2 ANTAGONISTS; HUMANS; LIVER TRANSPLANTATION; MULTIPLE ENDOCRINE NEOPLASIA; NEOPLASM METASTASIS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PARATHYROIDECTOMY; PROTON PUMPS; SOMATOSTATIN; VAGOTOMY; ZOLLINGER-ELLISON SYNDROME;

EID: 0035436865     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-001-0027-3     Document Type: Review

References (53)

1. 1. RM Zollinger 1955 Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas Ann Surg 142 709 728 13259432 10.1097/00000658-195510000-00015 1:STN:280:DyaG28%2FhtFegtg%3D%3D Zollinger RM: Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955, 142:709–728.
2. 2. JB Meko JA Norton 1995 Management of patients with Zollinger-Ellison syndrome Ann Rev Med 46 395 411 7598474 10.1146/annurev.med.46.1.395 1:CAS:528:DyaK2MXkvFSksb4%3D Meko JB, Norton JA: Management of patients with Zollinger-Ellison syndrome. Ann Rev Med 1995, 46:395–411.
3. 3. JA Norton 1998 Gastrinoma:advances in localization and treatment Surg Oncol Clin North Am 7 845 861 1:STN:280:DyaK1cvgs1eitQ%3D%3D Norton JA: Gastrinoma:advances in localization and treatment. Surg Oncol Clin North Am 1998, 7:845–861.
4. 4. PK Roy DJ Venzon H Shojamanesh 2000 Zollinger-Ellison syndrome. Clinical presentation in 261 patients Medicine (Baltimore) 79 379 411 10.1097/00005792-200011000-00004 1:STN:280:DC%2BD3M%2FntFKisg%3D%3D Roy PK, Venzon DJ, Shojamanesh H, et al.: Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) 2000, 79:379–411.
5. 5. SA Wells 1999 Surgery for the Zollinger-Ellison syndrome N Engl J Med 341 689 690 10460823 10.1056/NEJM199908263410911 Wells SA Jr: Surgery for the Zollinger-Ellison syndrome. N Engl J Med 1999, 341:689–690.
6. 6. JR Pisegna P Martin W McKeand 1999 Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole:a dose-response study Am J Gastroenterol 94 2874 2880 10520836 10.1111/j.1572-0241.1999.01430.x 1:CAS:528:DyaK1MXnt1SksLc%3D Pisegna JR, Martin P, McKeand W, et al.: Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole:a dose-response study. Am J Gastroenterol 1999, 94:2874–2880.
7. 7. JR Burgess TM Greenaway V Parameswaran JJ Shepherd 1999 Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1). Implications for an integrated model of MEN-1 tumorigenesis Cancer 86 2154 2159 10570446 10.1002/(SICI)1097-0142(19991115)86:10<2154::AID-CNCR39>3.0.CO;2-W 1:CAS:528:DyaK1MXotVOgt7w%3D Burgess JR, Greenaway TM, Parameswaran V, Shepherd JJ: Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1). Implications for an integrated model of MEN-1 tumorigenesis. Cancer 1999, 86:2154–2159.
8. 8. S Gaztambide JA Vazquez 1999 Short-and long-term effect of a long-acting somatostatin analogue, lanreotide (SR-L) on metastatic gastrinoma J Endocrinol Invest 22 144 146 10195383 1:STN:280:DyaK1M3gvFOmug%3D%3D Gaztambide S, Vazquez JA: Short-and long-term effect of a long-acting somatostatin analogue, lanreotide (SR-L) on metastatic gastrinoma. J Endocrinol Invest 1999, 22:144–146.
9. 9. EA Lew JR Pisegna JA Starr 2000 Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome Gastroenterology 118 696 704 10734021 10.1016/S0016-5085(00)70139-9 1:CAS:528:DC%2BD3cXis1ens78%3D Lew EA, Pisegna JR, Starr JA, et al.: Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology 2000, 118:696–704.
10. 10. PN Maton 1996 Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion Drugs 52 33 44 8799683 1:CAS:528:DyaK28XksVOnsLc%3D Maton PN: Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion. Drugs 1996, 52:33–44.
11. 11. B Termanini F Gibril VE Sutliff 1998 Effect of longterm gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome Am J Med 104 422 430 9626024 10.1016/S0002-9343(98)00087-4 1:CAS:528:DyaK1cXktVSjtbc%3D Termanini B, Gibril F, Sutliff VE, et al.: Effect of longterm gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am J Med 1998, 104:422–430.
12. 12. JR Saltzman JA Kemp BB Golner 1994 Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption J Am Coll Nutr 13 584 591 7706591 1:STN:280:DyaK2M3itFOmsw%3D%3D Saltzman JR, Kemp JA, Golner BB, et al.: Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J Am Coll Nutr 1994, 13:584–591.
13. 13. SK Dutta 1994 Vitamin B12 malabsorption and omeprazole therapy J Am Coll Nutr 13 544 545 7706583 1:STN:280:DyaK2M3itFOnsQ%3D%3D Dutta SK: Vitamin B12 malabsorption and omeprazole therapy. J Am Coll Nutr 1994, 13:544–545.
14. 14. CA Stewart B Termanini VE Sutliff 1998 Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy Aliment Pharmacol Ther 12 83 98 9692706 10.1046/j.1365-2036.1998.00274.x 1:CAS:528:DyaK1cXpslaltQ%3D%3D Stewart CA, Termanini B, Sutliff VE, et al.: Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy. Aliment Pharmacol Ther 1998, 12:83–98.
15. 15. G Cadiot T Lehy P Ruszniewski 1993 Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment Dig Dis Sci 38 1307 1317 8100759 10.1007/BF01296083 1:STN:280:DyaK3szhsVGjtw%3D%3D Cadiot G, Lehy T, Ruszniewski P, et al.: Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci 1993, 38:1307–1317.
16. 16. P Tomassetti M Migliori L Gullo 1998 Slow-release lanreotide treatment in endocrine gastrointestinal tumors Am J Gastroenterol 93 1468 1471 9732927 10.1111/j.1572-0241.1998.465_q.x 1:CAS:528:DyaK1cXmtFSnu7g%3D Tomassetti P, Migliori M, Gullo L: Slow-release lanreotide treatment in endocrine gastrointestinal tumors. Am J Gastroenterol 1998, 93:1468–1471.
17. 17. AN Wymenga B Eriksson PI Salmela 1999 Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms J Clin Oncol 17 1111 1111 10561168 1:CAS:528:DyaK1MXisFentbo%3D Wymenga AN, Eriksson B, Salmela PI, et al.: Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms. J Clin Oncol 1999, 17:1111. A description of what may be the next important wave in the treatment of gastrinoma (ie, long-acting somatostatin analogs).
18. 18. P Tomassetti M Migliori R Corinaldesi L Gullo 2000 Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR Aliment Pharmacol Ther 14 557 560 10792118 10.1046/j.1365-2036.2000.00738.x 1:CAS:528:DC%2BD3cXjvFSgs7Y%3D Tomassetti P, Migliori M, Corinaldesi R, Gullo L: Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR. Aliment Pharmacol Ther 2000, 14:557–560.
19. 19. JD Veldhuis JA Norton SA Wells 1997 Surgical versus medical management of multiple endocrine neoplasia (MEN) type I J Clin Endocrinol Metab 82 357 364 9024218 10.1210/jc.82.2.357 1:CAS:528:DyaK2sXhtVajsr8%3D Veldhuis JD, Norton JA, Wells SA Jr, et al.: Surgical versus medical management of multiple endocrine neoplasia (MEN) type I. J Clin Endocrinol Metab 1997, 82:357–364.
20. 20. JA Norton DL Fraker HR Alexander 1999 Surgery to cure the Zollinger-Ellison syndrome N Engl J Med 341 635 644 10460814 10.1056/NEJM199908263410902 1:STN:280:DyaK1MzotlKnsQ%3D%3D Elucidates the role of surgery in gastrinoma treatment, based on the largest contemporary series of patients in the literature. Norton JA, Fraker DL, Alexander HR, et al.: Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999, 341:635–644. Elucidates the role of surgery in gastrinoma treatment, based on the largest contemporary series of patients in the literature.
21. 21. B Termanini F Gibril JC Reynolds 1997 Value of somatostatin receptor scintigraphy:a prospective study in gastrinoma of its effect on clinical management Gastroenterology 112 335 347 9024287 10.1053/gast.1997.v112.pm9024287 1:STN:280:DyaK2s7ns1Onug%3D%3D Termanini B, Gibril F, Reynolds JC, et al.: Value of somatostatin receptor scintigraphy:a prospective study in gastrinoma of its effect on clinical management. Gastroenterology 1997, 112:335–347.
22. 22. O Kisker D Bartsch RJ Weinel 1997 The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors J Am Coll Surg 184 487 492 9145069 1:STN:280:DyaK2s3ptVCisA%3D%3D Kisker O, Bartsch D, Weinel RJ, et al.: The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors. J Am Coll Surg 1997, 184:487–492.
23. 23. HR Alexander DL Bartlett DJ Venzon 1998 Analysis of factors associated with long-term (five or more years) cure in patients undergoing operation for Zollinger-Ellison syndrome Surgery 124 1160 1166 9854598 10.1067/msy.1998.92010 1:STN:280:DyaK1M%2FntFOlsA%3D%3D A systemic analysis of the risk factors associated with cure/tumor recurrence, based on a large contemporary series of patients. Alexander HR, Bartlett DL, Venzon DJ, et al.: Analysis of factors associated with long-term (five or more years) cure in patients undergoing operation for Zollinger-Ellison syndrome. Surgery 1998, 124:1160–1166. A systemic analysis of the risk factors associated with cure/tumor recurrence, based on a large contemporary series of patients.
24. 24. O Kisker D Bastian D Bartsch 1998 Localization, malignant potential, and surgical management of gastrinomas World J Surg 22 651 657 9606277 10.1007/s002689900448 1:STN:280:DyaK1c3ntV2lug%3D%3D Kisker O, Bastian D, Bartsch D, et al.: Localization, malignant potential, and surgical management of gastrinomas. World J Surg 1998, 22:651–657.
25. 25. JA Norton GM Doherty DL Fraker 1998 Surgical treatment of localized gastrinoma within the liver:a prospective study Surgery 124 1145 1152 9854596 10.1067/msy.1998.93110 1:STN:280:DyaK1M%2FntFOlsg%3D%3D Important for description and discussion of the role of metastasectomy in gastrinoma, based on a large prospective study of patients undergoing surgery. Norton JA, Doherty GM, Fraker DL, et al.: Surgical treatment of localized gastrinoma within the liver:a prospective study. Surgery 1998, 124:1145–1152. Important for description and discussion of the role of metastasectomy in gastrinoma, based on a large prospective study of patients undergoing surgery.
26. 26. NT Jaskowiak DL Fraker HR Alexander 1996 Is reoperation for gastrinoma excision indicated in Zollinger-Ellison syndrome Surgery 120 1055 1062 8957495 10.1016/S0039-6060(96)80055-9 1:STN:280:DyaK2s7hs1CjtQ%3D%3D Jaskowiak NT, Fraker DL, Alexander HR, et al.: Is reoperation for gastrinoma excision indicated in Zollinger-Ellison syndrome ? Surgery 1996, 120:1055–1062.
27. 27. M Gagner A Pomp MF Herrera 1996 Early experience with laparoscopic resections of islet cell tumors Surgery 120 1051 1054 8957494 10.1016/S0039-6060(96)80054-7 1:STN:280:DyaK2s7hs1CjtA%3D%3D Gagner M, Pomp A, Herrera MF: Early experience with laparoscopic resections of islet cell tumors. Surgery 1996, 120:1051–1054.
28. 28. BI Hirschowitz 1999 Surgery to cure the Zollinger-Ellison syndrome N Engl J Med 341 2096 2097 10627201 10.1056/NEJM199912303412714 1:STN:280:DC%2BD3c%2Fmt1Sjuw%3D%3D Hirschowitz BI: Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999, 341:2096–2097.
29. 29. GQ Phan CJ Yeo JL Cameron 1997 Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors:fifty patients Surgery 122 989 996 9426411 10.1016/S0039-6060(97)90200-2 1:STN:280:DyaK1c%2FoslOqsw%3D%3D Phan GQ, Yeo CJ, Cameron JL, et al.: Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors:fifty patients. Surgery 1997, 122:989–996.
30. 30. T Sato K Konishi H Kimura 2000 Strategy for pancreatic endocrine tumors Hepatogastroenterology 47 537 539 10791232 1:STN:280:DC%2BD3c3ltFyhug%3D%3D Sato T, Konishi K, Kimura H, et al.: Strategy for pancreatic endocrine tumors. Hepatogastroenterology 2000, 47:537–539.
31. 31. AE Siperstein SJ Rogers PD Hansen A Gitomirsky 1997 Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases Surgery 122 1147 1154 9426432 10.1016/S0039-6060(97)90221-X 1:STN:280:DyaK1c%2FoslyisA%3D%3D Siperstein AE, Rogers SJ, Hansen PD, Gitomirsky A: Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997, 122:1147–1154.
32. 32. AJ Bilchik T Sarantou LJ Foshag 1997 Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy Surgery 122 1040 1047 9426418 10.1016/S0039-6060(97)90207-5 1:STN:280:DyaK1c%2FoslOqug%3D%3D Bilchik AJ, Sarantou T, Foshag LJ, et al.: Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. Surgery 1997, 122:1040–1047.
33. 33. M Shafir R Shapiro M Sung 1996 Cryoablation of unresectable malignant liver tumors Am J Surg 171 27 31 8554146 10.1016/S0002-9610(99)80068-3 1:STN:280:DyaK287kt1Srsw%3D%3D Shafir M, Shapiro R, Sung M, et al.: Cryoablation of unresectable malignant liver tumors. Am J Surg 1996, 171:27–31.
34. 34. CA Stewart B Termanini VE Sutliff 1997 Management of the Zollinger-Ellison syndrome in pregnancy Am J Obstet Gynecol 176 224 233 9024119 10.1016/S0002-9378(97)80041-5 1:STN:280:DyaK2s7ns1Grsg%3D%3D Stewart CA, Termanini B, Sutliff VE, et al.: Management of the Zollinger-Ellison syndrome in pregnancy. Am J Obstet Gynecol 1997, 176:224–233.
35. 35. KE McArthur CT Richardson CC Barnett 1996 Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome:results of a 16-year prospective study Am J Gastroenterol 91 1104 1111 8651153 1:STN:280:DyaK283jslKhsg%3D%3D McArthur KE, Richardson CT, Barnett CC, et al.: Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome:results of a 16-year prospective study. Am J Gastroenterol 1996, 91:1104–1111.
36. 36. RT Jensen 1996 Should the 1996 citation for Zollinger-Ellison syndrome read:“Acid-reducing surgery in, aggressive resection out” Am J Gastroenterol 91 1067 1070 8651148 1:STN:280:DyaK283jslKitw%3D%3D Jensen RT: Should the 1996 citation for Zollinger-Ellison syndrome read:“Acid-reducing surgery in, aggressive resection out” ? Am J Gastroenterol 1996, 91:1067–1070.
37. 37. T Gottwald G Koveker M Busing 1998 Diagnosis and management of metastatic gastrinoma by multimodality treatment including liver transplantation:report of a case Surgery Today 28 551 558 9607910 10.1007/s005950050182 1:STN:280:DyaK1c3mvV2htA%3D%3D Gottwald T, Koveker G, Busing M, et al.: Diagnosis and management of metastatic gastrinoma by multimodality treatment including liver transplantation:report of a case. Surgery Today 1998, 28:551–558.
38. 38. B Dousset D Houssin O Soubrane 1995 Metastatic endocrine tumors:is there a place for liver transplantation Liver Transplant Surg 1 111 117 10.1002/lt.500010208 1:STN:280:DyaK1c%2FgtlWmtw%3D%3D Dousset B, Houssin D, Soubrane O, et al.: Metastatic endocrine tumors:is there a place for liver transplantation ? Liver Transplant Surg 1995, 1:111–117.
39. 39. NW Thompson 1995 The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient J Intern Med 238 269 280 7673858 1:STN:280:DyaK2MvgsVWnsA%3D%3D 10.1111/j.1365-2796.1995.tb00934.x Thompson NW: The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 1995, 238:269–280.
40. 40. NW Thompson 1998 Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both J Intern Med 243 495 500 9681848 10.1046/j.1365-2796.1998.00307.x 1:STN:280:DyaK1czksFWksQ%3D%3D Thompson NW: Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 1998, 243:495–500.
41. 41. C Dotzenrath PE Goretzki K Cupisti 2001 Malignant endocrine tumors in patients with MEN 1 disease Surgery 129 91 95 11150038 10.1067/msy.2001.109500 1:STN:280:DC%2BD3M7ht1SntA%3D%3D Dotzenrath C, Goretzki PE, Cupisti K, et al.: Malignant endocrine tumors in patients with MEN 1 disease. Surgery 2001, 129:91–95.
42. 42. B Skogseid K Oberg B Eriksson 1996 Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I World J Surg 20 872 876 8678965 10.1007/s002689900133 1:STN:280:DyaK28vislagtQ%3D%3D Skogseid B, Oberg K, Eriksson B, et al.: Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 1996, 20:872–876.
43. 43. M Mignon G Cadiot 1998 Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1 J Intern Med 243 489 494 9681847 10.1046/j.1365-2796.1998.00287.x 1:STN:280:DyaK1czksFWksA%3D%3D Mignon M, Cadiot G: Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. J Intern Med 1998, 243:489–494.
44. 44. MP MacFarlane DL Fraker HR Alexander 1995 Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1 Surgery 118 973 979 7491542 10.1016/S0039-6060(05)80102-3 1:STN:280:DyaK28%2FovFSisg%3D%3D MacFarlane MP, Fraker DL, Alexander HR, et al.: Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 1995, 118:973–979.
45. 45. DL Fraker JA Norton ZA Saeed 1988 A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection Surgery 104 1054 1063 2904182 1:STN:280:DyaL1M%2FlvVyjsQ%3D%3D Fraker DL, Norton JA, Saeed ZA, et al.: A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection. Surgery 1988, 104:1054–1063.
46. 46. T vonSchrenck JM Howard JL Doppman 1988 Prospective study of chemotherapy in patients with metastatic gastrinoma Gastroenterology 94 1326 1334 1:STN:280:DyaL1c7ps1OmsA%3D%3D von Schrenck T, Howard JM, Doppman JL, et al.: Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 1988, 94:1326–1334.
47. 47. M Frank KJ Klose M Wied 1999 Combination therapy with octreotide and alpha-interferon:effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors Am J Gastroenterol 94 1381 1387 10235222 1:CAS:528:DyaK1MXjtlyqs70%3D Frank M, Klose KJ, Wied M, et al.: Combination therapy with octreotide and alpha-interferon:effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 1999, 94:1381–1387.
48. 48. W Creutzfeldt HH Bartsch U Jacubaschke F Stockmann 1991 Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide Acta Oncol 30 529 535 1713038 1:STN:280:DyaK3MzgslOrtg%3D%3D Creutzfeldt W, Bartsch HH, Jacubaschke U, Stockmann F: Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide. Acta Oncol 1991, 30:529–535.
49. 49. B Eriksson K Oberg 1993 An update of the medical treatment of malignant endocrine pancreatic tumors Acta Oncol 32 203 208 8391832 1:STN:280:DyaK3szht1GrsQ%3D%3D Eriksson B, Oberg K: An update of the medical treatment of malignant endocrine pancreatic tumors. Acta Oncol 1993, 32:203–208.
50. 50. G Ohshio R Hosotani M Imamura 1998 Gastrinoma with multiple liver metastases:effectiveness of dacarbazine (DTIC) therapy J Hepatobiliary Pancreat Surg 5 339 343 9880785 10.1007/s005340050056 1:STN:280:DyaK1M%2FpvFahug%3D%3D Ohshio G, Hosotani R, Imamura M, et al.: Gastrinoma with multiple liver metastases:effectiveness of dacarbazine (DTIC) therapy. J Hepatobiliary Pancreat Surg 1998, 5:339–343.
51. 51. M Bar M Burke A Isakov C Almog 1990 Insulinoma after streptozotocin therapy for metastatic gastrinoma:natural history or iatrogenic complication J Clin Gastroenterol 12 579 580 2172360 1:STN:280:DyaK3M%2Fjs1yjsg%3D%3D 10.1097/00004836-199010000-00018 Bar M, Burke M, Isakov A, Almog C: Insulinoma after streptozotocin therapy for metastatic gastrinoma:natural history or iatrogenic complication ? J Clin Gastroenterol 1990, 12:579–580.
52. 52. M Leimer A Kurtaran P Smith-Jones 1998 Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma J Nucl Med 39 2090 2094 9867148 1:CAS:528:DyaK1MXitVOnsA%3D%3D Leimer M, Kurtaran A, Smith-Jones P, et al.: Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma. J Nucl Med 1998, 39:2090–2094.
53. 53. B Gery A Roussel A Valla 1993 Usefulness of radiotherapy in the treatment of advanced gastrinomas [letter] Radiother Oncol 27 259 260 7692475 10.1016/0167-8140(93)90083-K 1:STN:280:DyaK2c%2FitlSktA%3D%3D Gery B, Roussel A, Valla A: Usefulness of radiotherapy in the treatment of advanced gastrinomas [letter]. Radiother Oncol 1993, 27:259–260.